Canaccord Genuity Group Issues Positive Forecast for LifeStance Health Group (NASDAQ:LFST) Stock Price

LifeStance Health Group (NASDAQ:LFST) had its target price increased by Canaccord Genuity Group from $15.00 to $16.00 in a research report released on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

A number of other research firms have also commented on LFST. KeyCorp boosted their price objective on LifeStance Health Group from $15.00 to $17.00 and gave the stock an “overweight” rating in a research note on Friday. Barclays increased their target price on LifeStance Health Group from $13.00 to $15.00 and gave the stock an “overweight” rating in a report on Thursday, September 10th. Zacks Research downgraded shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 13th. JPMorgan Chase & Co. upped their price target on shares of LifeStance Health Group from $9.00 to $13.00 and gave the stock a “neutral” rating in a research report on Friday, August 14th. Finally, Wall Street Zen lowered shares of LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, LifeStance Health Group has a consensus rating of “Moderate Buy” and a consensus price target of $13.75.

LifeStance Health Group Price Performance

Shares of NASDAQ:LFST traded up $0.34 during trading on Friday, reaching $13.77. The stock had a trading volume of 4,924,487 shares, compared to its average volume of 2,978,738. LifeStance Health Group has a 52 week low of $5.87 and a 52 week high of $15.66. The business’s 50-day moving average price is $12.62 and its 200 day moving average price is $9.49. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. The stock has a market capitalization of $5.26 billion, a PE ratio of 72.48 and a beta of 1.35.

LifeStance Health Group (NASDAQ:LFST) last announced its earnings results on Thursday, November 5th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. The business had revenue of $455.86 million for the quarter, compared to the consensus estimate of $431.59 million. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%. LifeStance Health Group’s revenue was up 25.3% compared to the same quarter last year. As a group, equities analysts predict that LifeStance Health Group will post 0.17 earnings per share for the current year.

Insider Buying and Selling at LifeStance Health Group

In other news, COO Lisa Miller sold 47,912 shares of LifeStance Health Group stock in a transaction on Monday, August 10th. The stock was sold at an average price of $10.85, for a total value of $519,845.20. Following the completion of the sale, the chief operating officer directly owned 281,289 shares of the company’s stock, valued at approximately $3,051,985.65. This trade represents a 14.55% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CTO Vukasin Paunovich sold 44,394 shares of the business’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $10.85, for a total value of $481,674.90. Following the sale, the chief technology officer owned 247,446 shares of the company’s stock, valued at approximately $2,684,789.10. The trade was a 15.21% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 13,777,580 shares of company stock worth $146,433,781. Insiders own 3.50% of the company’s stock.

Institutional Trading of LifeStance Health Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in LFST. Diversified Trust Co boosted its stake in shares of LifeStance Health Group by 5.7% in the 3rd quarter. Diversified Trust Co now owns 78,109 shares of the company’s stock valued at $940,000 after purchasing an additional 4,189 shares during the last quarter. Fifth Third Bancorp boosted its stake in LifeStance Health Group by 10.7% in the third quarter. Fifth Third Bancorp now owns 180,736 shares of the company’s stock valued at $2,174,000 after acquiring an additional 17,414 shares during the last quarter. Maryland State Retirement & Pension System boosted its stake in LifeStance Health Group by 80.5% in the third quarter. Maryland State Retirement & Pension System now owns 60,294 shares of the company’s stock valued at $725,000 after acquiring an additional 26,896 shares during the last quarter. Summit Creek Advisors LLC acquired a new stake in LifeStance Health Group during the 3rd quarter worth $2,408,000. Finally, StoneX Group Inc. acquired a new stake in LifeStance Health Group during the 3rd quarter worth $132,000. 85.50% of the stock is owned by institutional investors.

Trending Headlines about LifeStance Health Group

Here are the key news stories impacting LifeStance Health Group this week:

• Positive Sentiment: LifeStance reported Q3 adjusted earnings of $0.06 per share, ahead of estimates, and revenue of $455.9 million versus forecasts of about $431.6 million. Revenue grew 25.3% year over year, and the company raised its full-year outlook—evidence of stronger-than-expected performance. LifeStance Q3 results and outlook
• Positive Sentiment: Analysts raised their targets and maintained bullish ratings: KeyCorp lifted its target to $17 with an “overweight” rating, Canaccord Genuity raised its target to $16 with a “buy” rating, and BTIG increased its target to $20, also with a “buy” rating. These revisions signal greater optimism about potential upside. KeyCorp rating Canaccord Genuity rating BTIG target increase
• Neutral Sentiment: Coverage noted LFST reached a 52-week high and highlighted its momentum, though those signals alone do not establish whether further gains are sustainable. Zacks coverage of LFST’s high

About LifeStance Health Group

LifeStance Health Group, Inc is a provider of outpatient behavioral health services in the United States. Through a network of clinicians and care centers, the company offers mental health care through in-person appointments and telehealth visits.

LifeStance’s services include individual, couples and family therapy; psychiatric evaluation and medication management; psychological and neuropsychological testing; and treatment for conditions such as depression, anxiety, attention-deficit/hyperactivity disorder, bipolar disorder, post-traumatic stress disorder and other behavioral health concerns.